Comprehensive Prospective Comparison Of Two Robotic Platforms In Anatomical Lung Resections: Clinical Outcomes And Cost-utility Analysis
Conditions:
Pulmonary Nodule, Solitary
Lung Cancer (NSCLC)
Pulmonary Metastases
Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
trial.available_in:
БГ
Overview
The goal is to compare clinical outcomes, hospital costs, and cost-utility in patients undergoing anatomical lung resections with DaVinci Xi vs Versius platforms
The main questions it aims to answer are:
* Do patients that undergo an anatomical lung resection with DaVinci Xi have the same clinical outcomes (complications, stay...) than those who were operated with Versius?
* Are anatomical lung resections performed with DaVinci Xi more expensive than those performed with Versius?
* Are anatomical lung resection performed with DaVinci Xi more cost-effective than those performed with Versius?
Participants already undergoing robotic anatomical lung resection as part of their regular medical care will answer quality of life questionnaires preoperatively, at 1, 3, 6, and 12 months after surgery.
Who can participate
Inclusion Criteria:
* Patients that undergo segmentectomy or lobectomy with RATS.
Exclusion Criteria:
* Conversion to VATS at the beginning of the procedure